Organizing Committee Member
Dr. De haan, Lolke
Senior Director R&D
University of Groningen
Cambridge, United Kingdom
Biography
Dr. Lolke de Haan Senior Director R&D, Toxicology, Immuno-Oncology Nonclinical Safety Lead at MedImmune Cambridge, United Kingdom. Experienced immunologist & toxicologist, global nonclinical safety lead for immuno-oncology products and MedImmune Cambridge toxicology team manager. Lead toxicologist for Imfinzi (durvalumab), tremelimumab and a number of additional late discovery and early clinical stage cancer immunotherapy products.
Research Area
Immuno-Oncology Nonclinical Safety Lead at MedImmune